不同中成药治疗缺血性脑卒中急性期的临床疗效对比观察

Study of Different Chinese Medicine in Acute Ischemic Stroke

目的探讨不同中成药治疗缺血性脑卒中急性期的临床有效性。方法将112例患者随机分为对照组与观察组,对照组患者给予川芎嗪注射液治疗,观察组患者给予复方丹参注射液治疗,均采用静脉滴注的给药方式,观察比较不同中成药治疗缺血性脑卒中急性期的临床效果。结果对照组与观察组患者治疗前神经功能缺损评分、血瘀证证候积分、BI评分与FMA评分差异无统计学意义(P>0.05),两组患者治疗15、30 d后的神经功能缺损评分、血瘀证积分、BI评分与FMA评分差异均有统计学意义(均P<0.05);对照组患者缺血性脑卒中治疗有效率为73.21%,观察组为92.86%,差异有统计学意义(P<0.05)。结论采用复方丹参注射液的治疗方案可以显著改善缺血性脑卒中的各项指标,提高治疗缺血性脑卒中的治疗有效率,并且安全、有效。

Objective： To investigate the clinical effectiveness of Chinese medicine treatment of the acute phase of ischemic stroke. Methods： 112 patients with acute ischemic stroke patients with brain,according to the treatment of patients with ischemic stroke in the different processes used in Chinese medicine was randomly divided into the control group and the observation group.The control group were treated with Chuanxiongqin Injection and the observation group were treated with Compound Danshen Injection. Some indicators were compared between 2groups in the clinical effect. Results： There were no statistaical differnces between the control group and the observation group such as the neurological deficit scores,the blood stasis syndrome score,the BI score and the FMA score（P〉0.05）. In the two groups of patients 15 d,30d after neurological deficit score,blood stasis syndrome syndrome,BI score and FMA score were significantly different（P〈0.05）. There was remarkable difference between the effective rate with 73.21% in the control group and that with 92.86% in the observation group（P〈0.05）.Conclusion： The Compound Danshen Injection can significantly improve ischemic stroke indicators,to improve the treatment of ischemic stroke treatment efficient. It is safe and effective which can be worth more in-depth study.